HIV i-Base news story
Two cases of severe hyperglycemia have been reported several weeks after switching from stable oral ART to injectable long-acting cabotegravir/rilpivirine.
This is the first time this has been reported and the cases were published in the March 2026 issue of the journal Diabetes & Metabolism.
Both cases were men aged 60 and 62, with a history of hypertension but good CD4 counts on ART and viral load >30 copies/mL, who wanted to simplify treatment by switching.
Read the full news story here.
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.